KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Receivables (2016 - 2025)

Historic Receivables for Resmed (RMD) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.

  • Resmed's Receivables rose 1544.6% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 1544.6%. This contributed to the annual value of $990.7 million for FY2025, which is 1315.99% up from last year.
  • Resmed's Receivables amounted to $1.0 billion in Q4 2025, which was up 1544.6% from $958.4 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Receivables ranged from a high of $1.0 billion in Q4 2025 and a low of $534.2 million during Q1 2022
  • For the 5-year period, Resmed's Receivables averaged around $756.9 million, with its median value being $731.0 million (2023).
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 458.82% in 2021, then skyrocketed by 3330.66% in 2023.
  • Quarter analysis of 5 years shows Resmed's Receivables stood at $550.7 million in 2021, then rose by 26.27% to $695.4 million in 2022, then grew by 9.91% to $764.3 million in 2023, then rose by 18.66% to $907.0 million in 2024, then increased by 15.45% to $1.0 billion in 2025.
  • Its Receivables stands at $1.0 billion for Q4 2025, versus $958.4 million for Q3 2025 and $990.7 million for Q2 2025.